RecruitingNot ApplicableNCT05259410

Time Restricted Eating During Chemotherapy for Breast Cancer

The Safety and Efficacy of Time Restricted Eating Alone or Combined the Mediterranean Diet During Chemotherapy for Breast Cancer

Sponsor

University of Illinois at Chicago

Enrollment

40 participants

Start Date

Aug 1, 2022

Study Type

INTERVENTIONAL

Conditions

Breast Cancer Female

Summary

Breast cancer is the most common cancer in the United States however, little is known about how diet can affect cancer treatment. Pre-clinical murine studies report intermittent fasting increases effectiveness of chemotherapy and decreases treatment related adverse events. The proposed research will demonstrate that time restricted eating, a form of intermittent fasting, will improve treatment related outcomes, patient related outcomes, and limit treatment related weight gain and fat mass accretion.Time restricted eating combined with a mediterranean diet will also be feasible and improve cardiometabolic risk more than TRE alone or standard care.

Eligibility

Sex: FEMALEMin Age: 25 YearsMax Age: 99 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a time-restricted eating plan — eating all meals within a limited window of the day — in women with breast cancer who are undergoing chemotherapy. Researchers want to see if this approach is safe and whether it helps reduce side effects or improves cancer outcomes. **You may be eligible if...** - You are between 25 and 99 years old - You have been diagnosed with Stage I, II, or III breast cancer (confirmed by biopsy) - You are in generally good health and functional (ECOG 0 or 1) - You are not pregnant or breastfeeding - You are able to follow study instructions and dietary guidance **You may NOT be eligible if...** - You have Stage IV (metastatic) breast cancer - Your blood counts are too low to safely receive chemotherapy - You are pregnant or breastfeeding - You are unable to understand or follow the study requirements Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALTRE

All food eaten within the same self-selected 8 hour eating window daily, water fasting the remaining hours of the day.

BEHAVIORALMedTRE

A mediterranean style diet will be eaten within the same self-selected 8 hour eating window daily, water fasting the remaining hours of the day.

Locations(1)

University of Illinois Chicago

Chicago, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05259410

Related Trials

Evaluation of Safety of Acellular Dermal Matrix(ADM) in Breast Reconstruction

NCT065556141 location

TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients

NCT055351923 locations

ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer

NCT071987241 location

ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE)

NCT075057971 location

Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial

NCT0507231447 locations